AMBALAL SARABHAI ENTERPRISES LTD. - Announcement Under Regulation 30 Of SEBI(LODR) Regulations,2015

AMBALAL SARABHAI ENTERPRISES LTD. - Announcement Under Regulation 30 Of SEBI(LODR) Regulations,2015 - Updates

Download	< Back
26 Nov 2020
We wish to inform you that CoSara Diagnostics Private Limited, a Joint Venture of a subsidiary of Ambalal Sarabhai Enterprises Limited and Co-Diagnostics, Inc, Salt Lake City, Utah, USA recently got permission to manufacture COVID-19 test with two target genes (RdRP & E) from CDSCO.<BR> <BR> Like one gene test, this test is also highly specific and sensitive with fast and accurate diagnosis of COVID-19 infection with precise accuracy.<BR> <BR> This is one more step towards commitment of providing diagnostic kits helpful in early diagnosis, evaluation and management of treatment.<BR> <BR> You are requested to take the same on your record.<BR>
View all announcements for AMBALAL SARABHAI ENTERPRISES LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us